Inari Medical Inc (NARI): Market Cap to Revenue

Symbol and logo of brand Inari Medical Inc (NARI)

Inari Medical, Inc. (NARI) is optimizing its supply chains by outsourcing sterilization and logistics to external partners. Growth is driven by increasing interest in minimally invasive thrombosis treatments and expansion into foreign markets. Competition in the device segment creates pressure, which is offset by a strong clinical foundation. The price-to-sales ratio on this chart visualizes the business's market value, while the 8.10 indicator confirms the current level.

NARI Inari Medical Inc P/S Multiple (07/04/2022 - 03/01/2025)

Analytical breakdowns for Inari (NARI)

- share price and consensus valuation forecast:
Price Performance Chart inarimedical.com|NARI - Price Target Chart
- stock exchange capitalization data:
Market Valuation Inari|NARI - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share Inari Medical|NARI - Book Capitalization|Capitalization to Book Value Ratio inarimedical.com|NARI - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Inari Medical, Inc.|NARI - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Inari Medical Corp|NARI - Company Aggregate Debts|Debts to Book Capitalization Inari|NARI - Company Long-Term Debt|Company Short-Term Debt Inari Medical|Intermediate Coverage Ratio inarimedical.com
- earnings and multiples data:
NARI - Net Profit|Expected Net Profit Inari Medical, Inc.|NARI - Price to Earnings Ratio|Forward Price to Earnings Multiple Inari Medical Inc|NARI - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Inari|NARI - Operating profit EBITDA|Net earnings per share for the last four quarters Inari Medical|NARI - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months inarimedical.com|NARI - Earnings per share growth in current year|Expected earnings per share growth for next year Inari Medical, Inc.
- issuer revenue and sales details:
NARI - Revenue and Sales Volume|Company Expected Sales Volume inarimedical.com|NARI - Price-to-Revenue Ratio|Market Cap to Projected Revenue Inari
General company analysis:NARI inarimedical.com
Core merchandise of Inari Medical, Inc.

The ratio of Inari Medical, Inc. (NARI) market capitalization to annual sales reflects the premium the market is willing to pay for the growth potential of thrombosis treatment technologies. By analyzing the fundamental P/S, an investor compares the business value with actual cash flows, assessing the resilience of the share price against risks such as reduced insurance reimbursements or competitor expansion within the minimally invasive therapy segment.

Competitors of Inari Medical, Inc.

DXCM (dexcom.com) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Penumbra PEN|NOVT - Market Cap to Revenue|Haemonetics Corp. - P/S Multiple|Price to Sales Inspire Medical Systems Inc|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Biosciences) - P/S Multiple|InMode Ltd (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics Inc. SRDX|P/S Multiple SENS (Senseonics Holdings)|P/S Multiple neuropace.com NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|OM (Outset) - Market Cap to Revenue|Electromed - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR, Inc.) - P/S Multiple|Price to Sales avitamedical.com RCEL|Price-to-Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Price-to-Revenue Multiple|EDAP TMS - Market Cap to Revenue|P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corporation)|Price-to-Revenue Ratio Sensus Healthcare Corp|Market Cap to Revenue Zynex Corp (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Revenue Ratio|IRIX: Market Cap to Revenue|Intelligent Bio Solutions - Market Cap to Sales Volume|XAIR: P/S Multiple|PFSA - Price-to-Revenue Coefficient|Price-to-Revenue Ratio STRATA Skin Sciences Inc.|Market Cap to Revenue Ratio GCTK (glucotrack.com)|P/S Multiple NAOV|P/S Multiple Venus Concept Corporation (VERO)|Price-to-Revenue Ratio Nuwellis, Inc. NUWE|Market Capitalization-to-Revenue Ratio AEMD|TransEnterix - P/S Multiple|Price-to-Revenue Coefficient Avinger Inc. AVGR|BSGM (BioSig Technologies, Inc) - Market Cap to Revenue|Cutera Inc - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Know Labs, Inc.|Market Cap to Revenue nevro.com (NVRO)|P/S Multiple RSLS|SILK - Price to Sales